154 related articles for article (PubMed ID: 38162885)
1. Tuberculosis patients with special clinical conditions treated with contezolid: three case reports and a literature review.
Wang J; Ma L
Front Med (Lausanne); 2023; 10():1265923. PubMed ID: 38162885
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients.
Wang J; Nie W; Ma L; Li Q; Geng R; Shi W; Chu N
Infect Drug Resist; 2023; 16():6237-6245. PubMed ID: 37745897
[TBL] [Abstract][Full Text] [Related]
3. Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid-a typical case report and literature review.
Li J; Yu Z; Jiang Y; Lao S; Li D
Front Cell Infect Microbiol; 2023; 13():1258561. PubMed ID: 37908760
[TBL] [Abstract][Full Text] [Related]
4. Case report: Successful treatment with contezolid in a patient with tuberculous meningitis who was intolerant to linezolid.
Xu Z; Zhang J; Guan T; Wan G; Jiang C; Lang L; Wang L
Front Med (Lausanne); 2023; 10():1224179. PubMed ID: 37928457
[TBL] [Abstract][Full Text] [Related]
5. Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment.
Li B; Liu Y; Luo J; Cai Y; Chen M; Wang T
Front Pharmacol; 2023; 14():1157437. PubMed ID: 37168994
[TBL] [Abstract][Full Text] [Related]
6. Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
Yang M; Zhan S; Fu L; Wang Y; Zhang P; Deng G
Drug Discov Ther; 2022 May; 16(2):99-101. PubMed ID: 35418550
[TBL] [Abstract][Full Text] [Related]
7. A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections.
Zhao X; Huang H; Yuan H; Yuan Z; Zhang Y
J Antimicrob Chemother; 2022 May; 77(6):1762-1769. PubMed ID: 35265985
[TBL] [Abstract][Full Text] [Related]
8. Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis.
Almeida D; Li S-Y; Lee J; Hafkin B; Mdluli K; Fotouhi N; Nuermberger EL
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0078923. PubMed ID: 37966090
[TBL] [Abstract][Full Text] [Related]
9. Concentration of contezolid in cerebrospinal fluid and serum in a patient with tuberculous meningoencephalitis: A case report.
Guo W; Hu M; Xu N; Shangguan Y; Xia J; Hu W; Li X; Zhao Q; Xu K
Int J Antimicrob Agents; 2023 Aug; 62(2):106875. PubMed ID: 37276894
[TBL] [Abstract][Full Text] [Related]
10. Contezolid in complicated skin and soft tissue infection.
Kaul G; Dasgupta A; Chopra S
Drugs Today (Barc); 2022 Jul; 58(7):315-326. PubMed ID: 35851867
[TBL] [Abstract][Full Text] [Related]
11.
An H; Sun W; Liu X; Wang T; Qiao J; Liang J
Microbiol Spectr; 2023 Sep; 11(5):e0462722. PubMed ID: 37732805
[TBL] [Abstract][Full Text] [Related]
12. Drug Degradation Caused by
Pi R; Chen X; Meng J; Liu Q; Chen Y; Bei C; Wang C; Gao Q
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0103422. PubMed ID: 36190243
[TBL] [Abstract][Full Text] [Related]
13. New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?
Chen RH; Burke A; Cho JG; Alffenaar JW; Davies Forsman L
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931939
[TBL] [Abstract][Full Text] [Related]
14. Severe Community-Acquired Pneumonia Caused by Methicillin-Sensitive
Wang K; Hu Y; Duan Z; Fu H; Hu X; Zhao Y; Wen R; Li L; Xie F
Infect Drug Resist; 2023; 16():3233-3242. PubMed ID: 37249965
[TBL] [Abstract][Full Text] [Related]
15.
Wang S; Cai C; Shen Y; Sun C; Shi Q; Wu N; Zheng S; Qian J; Zhang R; Zhou H
Front Microbiol; 2021; 12():729900. PubMed ID: 34489919
[TBL] [Abstract][Full Text] [Related]
16. Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity.
Wang W; Voss KM; Liu J; Gordeev MF
Chem Res Toxicol; 2021 May; 34(5):1348-1354. PubMed ID: 33913699
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
[TBL] [Abstract][Full Text] [Related]
18. Use of Contezolid for the Treatment of Refractory Infective Endocarditis in a Patient with Chronic Renal Failure: Case Report.
Zhao S; Zhang W; Zhang L; Zhang J; Li J; Si L; Ding Y; Li M; Song Y
Infect Drug Resist; 2023; 16():3761-3765. PubMed ID: 37333679
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration.
Wang XK; Yu J; Xie CY; Hu XX; Nie TY; Li X; Wang PH; Li GQ; Yuan H; Yang XY; Li CR; You XF
J Antimicrob Chemother; 2023 Jul; 78(7):1632-1636. PubMed ID: 37202829
[TBL] [Abstract][Full Text] [Related]
20. A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
Guo Q; Xu L; Tan F; Zhang Y; Fan J; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0088921. PubMed ID: 34460305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
